Breaking News

Charles River Labs Acquires Distributed Bio

Establishes integrated, large molecule discovery platform.

By: Contract Pharma

Contract Pharma Staff

Charles River Laboratories has acquired Distributed Bio, Inc. for $83 million in cash, subject to customary closing adjustments. The acquisition marks the culmination of an exclusive partnership between the companies initiated in October 2018.   Based in South San Francisco, CA, Distributed Bio is a next-gen antibody discovery company. Its SuperHuman antibody libraries and integrated antibody optimization technologies help to enhance the probability of success for delivering high-quality, read...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters